Codexis (CDXS) EPS (Diluted) Growth (3y) (2013 - 2026)
Codexis (CDXS) EPS (Diluted) Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 78.99% |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 37.28% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 14.39% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -2.00% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 83.94% |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Codexis | 135.70 Mn | 70.56 Mn | 13.18 Mn | 34.61% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 34.61% |
| Dec 31, 2025 | 37.00% |
| Sep 30, 2025 | -12.48% |
| Jun 30, 2025 | -56.65% |
| Mar 31, 2025 | -25.05% |
| Dec 31, 2024 | 3.61% |
| Sep 30, 2024 | -120.01% |
| Jun 30, 2024 | -69.67% |
| Mar 31, 2024 | -5.30% |
| Dec 31, 2023 | -16.92% |
| Sep 30, 2023 | -69.51% |
| Jun 30, 2023 | -16.62% |
| Mar 31, 2023 | -38.21% |
| Dec 31, 2022 | -157.98% |
| Sep 30, 2022 | -208.44% |
| Jun 30, 2022 | 30.68% |
| Mar 31, 2022 | -10.24% |
| Dec 31, 2021 | -163.75% |
| Sep 30, 2021 | 42.49% |
| Jun 30, 2021 | 5.15% |